Eribulin mesylate is a potent, non-taxane microtubule dynamics inhibitor utilized in the treatment of metastatic breast cancer and liposarcoma. This category features high-quality reference standards for… Read more
![Chemical structure of (1R,2S,3S,4S,5S,6R,11S,14S,17S,19R,21R,23S,25R,26R,27S,31R,34S)-25-[(2S)-3-Amino-2-hydroxypropyl]-2,5-dihydroxy-26-methoxy-19-methyl-13,20-dimethylidene-24,35,36,37,38,39-hexaoxaheptacyclo[29.3.1.13,6.14,34.111,14.117,21.023,27]nonatriacontane-8,29-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R2S3S4S5S6R11S14S17S19R21R23S25R26R27S31R34S-25-2S-3-Amino-2-hydroxypropyl-25-dihydroxy-26-methoxy-19-methyl-1320-dimethylidene-243536373839-hexaoxah.png&w=3840&q=75)
![Chemical structure of (1R,3S,8S,11S,14S,16R,18R,20S,22R,23R,24S,28R,31S,33S,34R,35S,37S)-22-[(2S)-3-Amino-2-hydroxypropyl]-34,37-dihydroxy-23-methoxy-16-methyl-10,17-dimethylidene2,21,32,36,38,39-hexaoxaheptacyclo[26.6.2.13,33.18,11.114,18.020,24.031,35 ]nonatriacontane-5,26-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R3S8S11S14S16R18R20S22R23R24S28R31S33S34R35S37S-22-2S-3-Amino-2-hydroxypropyl-3437-dihydroxy-23-methoxy-16-methyl-1017-dimethylidene22132363839-hexao.png&w=3840&q=75)
![Chemical structure of (2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-2-[(2R)-3-Amino-2-hydroxypropyl]-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1190091-21-4-2R3R3aS7R8aS9S10aR11S12R13aR13bS15S18S21S24S26R28R29aS-2-2R-3-Amino-2-hydroxypropyl-3-methoxy-26-methyl-2027-dimethylidenehexacosahydro-1.png&w=3840&q=75)
![Chemical structure of (2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-2-[(2S)-2,3-Dihydroxypropyl]-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2?,3?:5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F253128-15-3-2R3R3aS7R8aS9S10aR11S12R13aR13bS15S18S21S24S26R28R29aS-2-2S-23-Dihydroxypropyl-3-methoxy-26-methyl-2027-dimethylidenehexacosahydro-1115182.png&w=3840&q=75)
![Chemical structure of 7,11:10,14:13,16:21,24:27,31-Pentaepoxy-2H-cyclohentriaconta[b]furan-5,18(3H,4H)-dione, 2-[(2S)-3-amino-2-hydroxypropyl]octacosahydro-12,15-dihydroxy-3-methoxy-29-methyl-23,30-bis(methylene)-, (2R,3R,3aS,7R,10S,11R,12S,13S,14S,15S,16R,21S,24S,27S,29R,31R,32aS)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1534341-96-2-7111014131621242731-Pentaepoxy-2H-cyclohentriacontabfuran-5183H4H-dione-2-2S-3-amino-2-hydroxypropyloctacosahydro-1215-dihydroxy-3-methox.png&w=3840&q=75)


Eribulin mesylate is a potent, non-taxane microtubule dynamics inhibitor utilized in the treatment of metastatic breast cancer and liposarcoma. This category features high-quality reference standards for eribulin mesylate API, along with its critical degradation products, pharmacopeial impurities, and stable isotope-labelled compounds. Pharmaceutical laboratories rely on these specialized reference materials for rigorous impurity profiling, method validation, and routine quality control during the manufacturing process. By providing traceable standards for known substances—including impurities defined by pharmacopeial monographs and non-pharmacopeial related compounds—these products enable accurate quantification and structural identification. Stable isotope-labelled analogues are particularly valuable for researchers performing precise quantitative analysis or investigating pharmacokinetic pathways. Access to this comprehensive range of materials supports the development of robust analytical methods essential for maintaining safety and consistency in the production of this complex antineoplastic agent.